Logotype for Specialized Medical Company

Specialized Medical Company (4019) Q1 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Specialized Medical Company

Q1 2026 earnings summary

12 May, 2026

Executive summary

  • Achieved resilient operational and financial performance in Q1 2026, with net profit up 9.8% year-over-year, driven by expansion of outpatient and acute care services and strategic shift from long-term care to higher-margin offerings.

  • Launched SMC Clinics in Al Malqa, with 14 clinics operational by March 2026 and further expansion planned throughout the year.

  • Maintained strong focus on patient experience, technology integration, and clinical excellence, receiving multiple awards and accreditations.

  • Strengthened balance sheet with net debt/EBITDA reduced to 1.7x and cash and cash equivalents up 66.6% year-over-year.

  • Interim condensed consolidated financial information reviewed for Q1 2026, with no material misstatements identified by the independent auditor.

Financial highlights

  • Net revenue grew 3.3% year-over-year to SAR 380.7 million, with EBITDA up 5.6% to SAR 69.3 million and net profit rising 9.8% to SAR 32.5 million; margins improved to 18.2% (EBITDA) and 8.6% (net profit).

  • Operating cash flow reached SAR 83.4 million; free cash flow was SAR 69.7 million; cash and cash equivalents stood at SAR 246.7 million.

  • Basic and diluted EPS for Q1 2026 was 0.13 SAR, up from 0.12 SAR in Q1 2025.

  • Sequentially, net revenue declined 6.4% from Q4 2025 due to seasonality and absence of a one-off gain from land sale in Q4.

  • Net debt decreased 10.9% year-over-year to SAR 719.9 million; debt/equity ratio reduced to 53% from 74%.

Outlook and guidance

  • FY 2026 guidance unchanged: net revenue targeted at 1.6–1.7 billion, EBITDA margin at 23–25%, and net income margin at 14–16%.

  • CapEx guidance through 2029 exceeds SAR 3 billion, primarily for three new hospitals, funded by debt and internal cash flows.

  • Management remains confident in meeting full-year guidance despite Q1 seasonality and regional uncertainties, with ongoing monitoring for material changes.

  • Committed to multi-year growth strategy focused on expanding integrated healthcare platform and optimizing service mix.

  • Further rollout of SMC Clinics in Al Malqa expected throughout 2026, with full capacity of 35 clinics.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more